Chemoattraction: Basic Concepts and Role in the Immune Response

Chemoattraction is defined as the unidirectional movement of a cell, in response to a chemical gradient of ligands. During chemoattraction the cells move in the direction from a low to a high concentration of the chemoattractant. Chemoattraction is called ‘chemotaxis’ when the ligand gradient is soluble and ‘haptotaxis’ when this gradient is bound to the substrate. Chemoattraction plays a fundamental role in the regulation of the precise location of leucocytes during the immune response and consequently is fundamental for the adequate functioning of the immune system.

Keywords: chemotaxis; haptotaxis; chemokinesis; chemokine; chemokine receptor

Figure 1. Structure of chemokines. See text for details. Reproduced from Fernández and Lolis, 2002 with permission from Annual Reviews.
Figure 2. Chemokine-activated intracellular signalling pathways. AC, adenyl cyclase; Bad, Bcl-2/Bcl-XL-antagonist, causing cell death; Cdc42, small GTPase of the Rho family; DAG, diacylglycerol; Dia, Diaphanous formin protein family; eIF2B, eukaryotic initiation factor 2B; ERK, extracellular signal-regulated kinase; FA, focal adhesion; GSK3, glycogen synthase kinase 3; IP3, Ins(1,4,5)P3; JAK, Janus kinase; LIMK, LIM-motif-containing kinase; MEK, mitogen-activated protein kinase/ERK kinase; MLCK, myosin light-chain kinase; MLCP, myosin light-chain phosphatase; MT, microtubulae organization, actin/myosin dynamics; mTOR, mammalian target of rapamycin; p70 S6 K, p70 S6 kinase; PAK, p21-activated kinase; PDK, phosphoinositide-dependent kinase; PIP2, PtdIns(4,5)P2; PI4P5 K, phosphoinositide 4-phosphate 5-kinase; PKA, protein kinase A (cAMP-dependent protein kinase); PKC, protein kinase C; PLC, phospholipase C; PTK, protein tyrosine kinase; ROCK, Rho-associated coiled-coil-containing kinase; SF, S-filament; STAT, signal transduction and activator of transcription; WASp, Wiskott–Aldrich syndrome protein; WAVE, WASp-family verprolin homologous protein. Reproduced from Johnson et al. (2004) Biochemical Society Transactions 32: 366. With permission from the Biochemical Society.
close
 References
    Cabrera-Vera TM, Vanhauwe J, Thomas TO et al. (2003) Insights into G protein structure, function, and regulation. Endocrine Reviews 24: 765–781.
    Campbell DJ, Debes GF, Johnston B, Wilson E and Butcher EC (2003) Targeting T cell responses by selective chemokine receptor expression. Seminars in Immunology 15: 277–286.
    Charo IF and Ransohoff RM (2006) Mechanisms of disease: the many roles of chemokines and chemokine receptors in inflammation. New England Journal of Medicine 354: 610–621.
    Chiang N, Serhan CN, Dahlen SE et al. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacological Reviews 58: 463–487.
    Dormann D and Weijer CJ (2006) Imaging of cell migration. EMBO Journal 25: 3480–3493.
    Fernandez EJ and Lolis E (2002) Structure, function, and inhibition of chemokines. Annual Review of Pharmacology and Toxicology 42: 469–499.
    Haeggstrom JZ (2004) Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis. Journal of Biological Chemistry 279: 50639–50642.
    Johnson Z, Power CA, Weiss C et al. (2004) Chemokine inhibition – why, when, where, which and how?. Biochemical Society Transactions 32: 366–377.
    Lefkowitz RJ, Rajagopal K and Whalen EJ (2006) New roles for -arrestin in cell signaling: not just for seven-transmembrane receptors. Molecular Cell 24: 643–652.
    Locati M, Torre YM, Galliera E et al. (2005) Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine & Growth Factor Reviews 16: 679–686.
    Luster AD (1998) Mechanisms of disease: chemokines–chemotactic cytokines that mediate inflammation. New England Journal of Medicine 338: 436–445.
    Mantovani A, Sica A, Sozzani S et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 25: 677–686.
    Moser B, Wolf M, Walz A and Loetscher P (2004) Chemokines: multiple levels of leucocyte migration control. Trends in Immunology 25: 75–84.
    Oppermann M (2004) Chemokine receptor CCR5: insights into structure, function, and regulation. Cell Signalling 16: 1201–1210.
    Panaro MA, Acquafredda A, Sisto M et al. (2006) Biological role of the N-formyl peptide receptors. Immunopharmacology and Immunotoxicology 28: 103–127.
    Prescott SM, Zimmerman GA, Stafforini DM and McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annual Review of Biochemistry 69: 419–445.
    Radeke HH, Ludwig RJ and Boehncke WH (2005) Experimental approaches to lymphocyte migration in dermatology in vitro and in vivo. Experimental Dermatology 14: 641–666.
    Randolph GJ, Angeli V and Swartz MA (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nature Reviews Immunology 5: 617–628.
    Riedemann NC, Guo RF and Ward PA (2003) A key role of C5a/C5aR activation for the development of sepsis. Journal leucocyte Biology 74: 966–970.
    Sanchez-Sanchez N, Riol-Blanco L and Rodriguez-Fernandez JL (2006) The multiple personalities of the chemokine receptor CCR7 in dendritic cells. Journal of Immunology 176: 5153–5159.
    Stein JV and Nombela-Arrieta C (2005) Chemokine control of lymphocyte trafficking: a general overview. Immunology 116: 1–12.
    Weber C and Koenen RR (2006) Fine-tuning leucocyte responses: towards a chemokine ‘interactome’. Trends in Immunology 27: 268–273.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Rodríguez‐Fernández, José Luis, and Riol‐Blanco, Lorena(Jul 2007) Chemoattraction: Basic Concepts and Role in the Immune Response. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0000507.pub2]